Clinical trial
An Open Label, Pharmacokinetic and Safety Study of Combogesic® IV in Pediatric Patients With Acute Pain
NCT07225634 is registered in ClinicalTrials.gov with AFT Pharmaceuticals, Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label, Pharmacokinetic and Safety Study of Combogesic® IV in Pediatric Patients With Acute Pain
- Lead sponsor
- AFT Pharmaceuticals, Ltd.
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- September 14, 2026
- Completion date
- April 30, 2027
- Enrollment
- 60 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.